GlassScriptPhysician profile
James M Frix
NPI 1396838363
$19,275.08
in general payments reported to CMS, 2019-2025
32 companies · $2,715 in 2025
The $2,715 reported for 2025 was more than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,090 · 2020: $760 · 2021: $3,653 · 2022: $1,442 · 2023: $5,068 · 2024: $548 · 2025: $2,715.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,833 · Food and Beverage: $3,497.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,833.40 |
| Food and Beverage | $3,497.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $6,287.86 | 2019-2025 | |
| Alpha Orthopedic Systems | $5,136.78 | 2019-2022 | |
| Smoky Mountain Surgical LLC | $3,352.00 | 2023-2025 | |
| Stryker Corporation | $2,053.12 | 2019-2025 | Blueprint Patient Specific Instrumentation, Air, Tornier Perform Anatomic Augmented Glenoid |
| Linvatec Corporation | $304.54 | 2023 | Biobrace 23mm, Allograft Tissue, Linvatec Positioning Devices |
| Zimmer Biomet Holdings, INC. | $300.86 | 2019-2025 | |
| Radius Health, INC. | $253.77 | 2019-2024 | Tymlos |
| Osteoremedies, LLC | $229.12 | 2019 | |
| Depuy Synthes Sales INC. | $228.40 | 2019-2022 | |
| Amgen INC. | $198.26 | 2019-2020 | |
| Smith+Nephew, INC. | $170.46 | 2022-2025 | Legion Revision, Real Intelligence |
| Innovation Technologies INC | $149.78 | 2023 | Irrisept |
| Team 1, LLC | $143.47 | 2024 | |
| Bioventus LLC | $62.13 | 2019-2025 | Xcell |
| Pacira Therapeutics, INC. | $59.64 | 2019-2020 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $58.89 | 2023-2025 | Exparel, Iovera, Zilretta |
| Vertex Pharmaceuticals Incorporated | $32.21 | 2025 | |
| Molnlycke Health Care US, LLC | $27.28 | 2025 | Avance, Mepilex Border Post-Op Ag |
| Shoulder Innovations, INC. | $24.72 | 2024 | Inset System |
| Nalu Medical, INC. | $24.37 | 2025 | Nalu Neurostimulation System |
| Vericel Corporation | $22.74 | 2019 | |
| Medtronic, INC. | $17.91 | 2023 | Kyphon Express II Kyphopak Tray |
| Alexion Pharmaceuticals, INC. | $17.38 | 2019 | |
| Abbvie INC. | $16.50 | 2023 | |
| Kci USA, INC. | $14.95 | 2023 | Prevena Restor Axioform, Prevena Restor Arthroform, Prevena |
| Avanos Medical | $14.74 | 2019 | |
| Olympus America INC. | $13.20 | 2019 | |
| Paragon 28, INC. | $12.95 | 2020 | |
| Convatec INC. | $12.67 | 2021 | |
| Ermi LLC | $12.60 | 2019 | |
| Ethicon US, LLC | $11.87 | 2020 | |
| Orthofix Medical, INC. | $9.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Frix listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.